Vitamin D3: A transcriptional modulator of the interferon-γ gene

European Journal of Immunology

Volumn 28, Issue 10, 1998, Pages 3017-3030

  Cippitelli, Marco ^a,b   Santoni, Angela ^a,b  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Calcitriol; Gene transcription; IFN ; Nuclear receptor; Vitamin D3 receptor

Indexed keywords

COLECALCIFEROL; GAMMA INTERFERON; RETINOID X RECEPTOR; CALCITRIOL; CALCITRIOL RECEPTOR; RETINOIC ACID RECEPTOR; TRANSCRIPTION FACTOR;

ARTICLE; DOWN REGULATION; ELECTROPHORETIC MOBILITY; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; PRIORITY JOURNAL; PROMOTER REGION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; ANIMAL; BINDING SITE; ENHANCER REGION; GENE DELETION; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; RAT;

ANIMALS; BINDING SITES; CALCITRIOL; ENHANCER ELEMENTS (GENETICS); GENE EXPRESSION REGULATION; HUMANS; INTERFERON TYPE II; JURKAT CELLS; PROMOTER REGIONS (GENETICS); RATS; RECEPTORS, CALCITRIOL; RECEPTORS, RETINOIC ACID; RETINOID X RECEPTORS; SEQUENCE DELETION; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 0031595992     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199810)28:10<3017::AID-IMMU3017>3.0.CO;2-6     Document Type: Article

References (40)

1. Bouillon, R., Okamura, W. H. and Norman, A. W., Structure-function relationships in the vitamin D endocrine system. Endocr. Rev. 1995. 16: 200-257.
2. Rigby, W. F. C., The immunobiology of vitamin D. Immunol. Today 1988. 9: 54-58.
3. 3 on human T lymphocyte activation and proliferation: a cell cycle analysis. J. Immunol. 1985. 135: 2279-2286.
4. 3. J. Clin. Invest. 1987. 79: 1659-1664.
5. 3. Blood 1990. 76: 2457-2461.
6. 3 receptor expression are developmentally regulated during differentiation of human monocytes into macrophages. Blood 1993. 82: 1300-1307.
7. 3 inhibits γ-interferon synthesis by normal human peripheral blood lymphocytes. Proc. Natl. Acad. Sci. USA 1987. 84: 3385-3389.
8. Saggese, G., Federico, G., Balestri, M. and Toniolo, A., Calcitriol inhibits the PHA-induced production of IL-2 and IFN-γ and the proliferation of human peripheral blood leukocytes while enhancing the surface expression of HLA class II molecules. J. Endocrinol. Invest. 1989. 12: 329-335.
9. 3: direct inhibition of NFATp/AP-1 complex formation by a nuclear hormone receptor. Mol. Cell. Biol. 1995. 15: 5789-5799.
10. 3. Proc. Natl. Acad. Sci. USA 1995. 92: 10990-10994.
11. Young, H. A. and Hardy, K. J., Interferon-γ: producer cells, activation stimuli, and molecular genetic regulation. Pharmacol. Ther. 1990. 45: 137-151.
12. Cippitelli, M., Sica, A., Viggiano, V., Ye, J., Ghosh, P., Birrer, M. J. and Young, H. A., Negative transcriptional regulation of the interferon-γ promoter by glucocorticoids and dominant negative mutants of c-Jun. J. Biol. Chem. 1995. 270: 12548-12556.
13. Cippitelli, M., Ye, J., Viggiano, V., Sica, A., Ghosh, P., Gulino, A., Santoni, A. and Young, H. A., Retinoic acid-induced transcriptional modulation of the human interferon-γ promoter. J. Biol. Chem. 1996. 271: 26783-26793.
14. Ye, J., Cippitelli, M., Dorman, L., Ortaldo, J. H. and Young, H. A., The nuclear factor YY1 suppresses the human gamma interferon promoter through two mechanisms: inhibition of AP1 binding and activation of a silencer element. Mol. Cell. Biol. 1996. 16: 4744-4753.
15. Penix, L., Weaver, W. M., Pang, Y., Young, H. A. and Wilson, C. B., Two essential regulatory elements in the human interferon-γ promoter confer activation specific expression in T cells. J. Exp. Med. 1993. 178: 1483-1496.
16. De Grazia, U., Felli, M. P., Vacca, A., Farina, A. R., Maroder, M., Cappabianca, L., Meco, D., Farina, M., Screpanti, I., Frati, L. and Gulino, A., Positive and negative regulation of the composite octamer motif of the interleukin-2 enhancer by AP-1, OCT-2, and retinoic acid receptor. J. Exp. Med. 1994. 180: 1485-1497.
17. Mukaida, N., Morita, M., Ishiikawa, Y., Rice, N., Okamoto, S., Kasahara, T. and Matsushima, K., Novel mechanism of glucocorticoid-mediated gene repression. J. Biol. Chem. 1994. 269: 13289-13295.
18. Vacca, A., Felli, M. P., Farina, A. R., Martinotti, S., Maroder, M., Screpanti, I., Meco, D., Petrangeli, E., Frati, L. and Gulino, A., Glucocorticoid receptor-mediated suppression of the interleukin-2 gene expression through impairment of the cooperativity betweeen nuclear factor of activated T cells and AP-1 enhancer elements. J. Exp. Med. 1992. 175: 637-646.
19. Ozono, K., Liao, J., Kerner, S. A., Scott, R. A. and Pike, J. W., The vitamin D-responsive element in the human osteocalcin gene. Association with a nuclear protooncogene enhancer. J. Biol. Chem. 1990. 265: 21881-21888.
20. Penix, L. A., Sweetser, M. T., Weaver, W. M., Hoeffler, J. P., Kerppola, T. K. and Wilson, C. B., The proximal regulatory element of the interferon-γ promoter mediates selective expression in T cells. J. Biol. Chem. 1996. 271: 31964-31972.
21. Yu, V. C., Delsert, C., Anderson, B., Holloway, J. M., Devary, O. V., Naar, A. M., Kim, S. Y., Boutin, J. M., Glass, C. K. and Rosenfeld, M. G., RXRβ: a coregulator that enhances binding of retinoic acid, thyroid hormone, and vitamin D receptors to their cognate response elements. Cell 1991. 67: 1251-1266.
22. 3 receptor (VDR) homodimers into VDR-retinoid X receptor heterodimers. Mol. Cell. Biol. 1994. 14: 3329-3338.
23. 3-activated expression of the rat osteocalcin gene. Mol. Cell. Biol. 1993. 13: 5907-5917.
24. Yang-Yen, H. J., Chambard, J. C., Sun, Y. L., Smeal, T., Schmidt, T. J., Drouin, J. and Karin, M., Transcriptional interference beetween c-Jun and the glucocorticoid receptor: mutual inhibition of DNA binding due to protein-protein interaction. Cell 1990. 62: 1205-1215.
25. Schule, R., Rangarajan, P., Yang, N., Kliewer, S., Ransone, L. J., Bolado, J., Verma, I. M. and Evans, R. M., Retinoic acid is a negative regulator of AP-1-responsive genes. Proc. Natl. Acad. Sci. USA 1991. 88: 6092-6096.
26. Schule, R., Ranganajan, P., Kliewev, S., Ransome, L. J., Bolado, J., Yang, N., Verma, I. M. and Evans, R. M., Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor. Cell 1990. 62: 1217-1226.
27. Scheinman, R. I., Gualberto, A., Jewell, C. M., Cidlowski, J. A. and Baldwin, A. S., Characterization of mechanisms involved in transrepression of NF-kB by activated glucocorticoid receptors. Mol. Cell. Biol. 1995. 15: 943-953.
28. Krishna, V., Chatterjee, K., Lee, J. K., Rentoumis, A. and Jameson, J. L., Negative regulation of the thyroid-stimulating hormone-a gene by thyroid hormone: receptor interaction adjacent to the TATA box. Proc. Natl. Acad Sci USA 1989. 86: 9114-9118.
29. Ray, A., LaForge, K. S. and Sehgal, P. B., On the mechanism for efficient repression of the interleukin-6 promoter by glucocorticoids: enhancer, TATA box, and RNA start site (Inr motif) occlusion. Mol. Cell. Biol. 1990. 10: 5736-5746.
30. Morrison, N. A., Shine, J., Fragonas, J. C., Verkest, V., McMenemy, M. L., Eisman, J. A., 1,25-dihydroxyvitamin D-responsive element and glucocorticoid repression in the osteocalcin gene. Science 1989. 246: 1158-1161.
31. Desai-Yajnik, V. and Samuels, H. H., The NF-kB and Sp1 motifs of the human immunodeficiency virus type 1 long terminal repeat functions as novel thyroid hormone response elements. Mol. Cell. Biol. 1993. 13: 5057-5069.
32. 3. J. Steroid Biochem. Mol. Biol. 1995. 53: 599-602.
33. Kamei, Y., Xu, L., Heinzel, T., Torchia, J., Kurokawa, R., Gloss, B., Lin, S. C., Heyman, R. A., Rose, D. W., Glass, C. K. and Rosenfeld, M. G., A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 1996. 85: 403-414.
34. 3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. Proc. Natl. Acad. Sci. USA 1996. 93: 7861-7864.
35. Cantorna, M. T., Nashold, F. E. and Hayes, C. E., Vitamin A deficiency results in a priming environment conducive for Th1 cell development. Eur. J. Immunol. 1995. 25: 1673-1679.
36. Racke, M. K., Burnett, D., Seong-Hee, P., Albert, P. S., Cannella, B., Raine, C. S., McFarlin, D. E. and Scott, D. E., Retinoid treatment of experimental allergic encephalomyelitis. J. Immunol. 1995. 154: 450-458.
37. 3 by interferon-γ-stimulated normal human bone marrow and alveolar macrophages. J. Biol. Chem. 1987. 262: 10931-10937.
38. Lu, C. Z., Jensen, M. A. and Arnason, B. G. W., Interferon gamma and interleukin-4-secreting cells in multiple sclerosis. J. Neuroimmunol. 1993. 46: 123-128.
39. Panitch, H. S., Hirsch, R. L., Haley, A. S. and Johnson, K. P., Exacerbations of multiple sclerosis in patients treated with gamma interferon. Lancet 1987. i: 893-895.
40. Woodroofe, M. N. and Cuzner, M. L., Cytokine mRNA expression in inflammatory multiple sclerosis lesions: detection by non-radioactive in situ hybridization. Cytokine 1993. 5: 583-588.